It has been established that more than mild large-droplet macrovesicular steatosis (LD-MAS) is associated with increased risk of graft non-function. In contrast, even severe small-droplet macrovesicular steatosis (SD-MAS) has been found to be less prognostically significant. It remains unclear if a donor liver with diffuse microvesicular steatosis is associated with an increased risk of graft dysfunction. A 56-year-old male with alcoholic cirrhosis was transplanted with a liver from a 42-year-old overweight male donor after brain death. The frozen section of the donor liver biopsy taken at harvest showed diffusely enlarged clear/foamy hepatocytes and mild LD-MAS (about 5-10% of total tissue). The reperfusion liver biopsy taken at time 0 of transplantation showed hemorrhage, pale and enlarged hepatocytes, and mild LD-MAS (about 10% of total tissue) with lipopeliosis. The graft became non-functional, and the patient was re-transplanted 24 h after the initial transplantation. Histologic examination of the failed liver allograft showed extensive hemorrhagic necrosis, neutrophilic inflammation, diffuse microvesicular steatosis, and large extracellular fat droplets (about 20% of total tissue). This case demonstrates that precautions are needed to avoid using livers with diffuse and severe microvesicular steatosis.
Keyphrases
- insulin resistance
- high fat diet
- high fat diet induced
- adipose tissue
- high throughput
- single cell
- oxidative stress
- low grade
- skeletal muscle
- metabolic syndrome
- type diabetes
- liver injury
- early onset
- case report
- magnetic resonance
- acute myocardial infarction
- cerebral ischemia
- computed tomography
- stem cells
- magnetic resonance imaging
- ultrasound guided
- weight loss
- blood brain barrier
- mesenchymal stem cells
- bone marrow
- percutaneous coronary intervention
- resting state
- functional connectivity
- kidney transplantation
- subarachnoid hemorrhage